Type
1.
Mathew C, Bettis A, Chu B, English M, Ottesen E, Bradley M, et al. The health and economic burden of lymphatic filariasis prior to mass drug administration programmes. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Internet]. 2019;. Available from: https://watermark.silverchair.com/ciz671.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAlswggJXBgkqhkiG9w0BBwagggJIMIICRAIBADCCAj0GCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMJz7b_5QjzswdK-gtAgEQgIICDmu1DpHLWlF0gsc7quhn5t0BL9mq4jx-imlybInOq8jg0kjB
Type
1.
Karim M, Haq R, Mableson H, Sultan Mahmood, Rahman M, Chowdhury S, et al. Developing the first national database and map of lymphatic filariasis clinical cases in Bangladesh: Another step closer to the elimination goals. PLoS neglected tropical diseases [Internet]. 2019;13(7):e0007542. Available from: https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0007542&type=printable
Type
1.
Hotez, Lo NC. Chapter 27 Neglected Tropical Diseases: Public Health Control Programs and Mass Drug Administration. In: Hunter’s Tropical Medicine and Emerging Infectious Diseases [Internet]. 10thth ed. Elsevier; 2020. pp. 209-13. Available from: https://www.sciencedirect.com/science/article/pii/B9780323555128000272
Type
1.
Tyagi BK, Joshi. Epidemiology of lymphatic filariasis. Singapore: Springer Singapore; 2018.
Type
1.
Tyagi BK, Khan, Dutta, Khan, Mahanta. Prevalence of lymphatic filariasis in the Northeastern States of India, with particular reference to Assam and prospects of elimination. In Singapore: Springer Singapore; 2018. pp. 149-64.
Type
1.
World Health Organization. Global programme to eliminate lymphatic filariasis: progress report, 2017. . Weekly epidemiological record [Internet]. 2018;91(44):589–604. Available from: http://apps.who.int/iris/bitstream/handle/10665/275719/WER9344.pdf
Type
1.
Koroma J, Sesay S, Conteh A, Paye J, Bah M, Sonnie M, et al. Progress on elimination of lymphatic filariasis in Sierra Leone. Parasites & vectors [Internet]. 2018;11(1):334. Available from: https://parasitesandvectors.biomedcentral.com/track/pdf/10.1186/s13071-018-2915-4
Type
1.
Kumar P, Waghmare R, Rajashekar. A study of socio-demographic & morbidity profile of lymphatic filariasis patients with lymphoedema om Warangal rural, Telangana. Paripex - Indian Journal of Research [Internet]. 2018;7(4):51-3. Available from: https://tinyurl.com/ybukmyk3
Type
1.
Derua Y, Kisinza W, Simonsen P. Lymphatic filariasis control in Tanzania: infection, disease perceptions and drug uptake patterns in an endemic community after multiple rounds of mass drug administration. Parasites & vectors [Internet]. 2018;11(1):429. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6053786/pdf/13071_2018_Article_2999.pdf
Type
1.
Mangeard-Lourme J. Building the case for the integration of mental health services in leprosy and lymphatic filariasis programmes. 2018 p. 6.